Rare snake bite- A case report

2022 ◽  
pp. 004947552110666
Author(s):  
Santosh Govind Rathod ◽  
Afaq Ahmad Khan ◽  
Sajad Ahmed Geelani ◽  
Reshma Roshan ◽  
Javid Rasool Bhat

Snake bite is an acute life threating medical emergency and is included amonst neglected tropical diseases. 1 Every year in India 200,000 people bitten by snakes and >25% are fatal. 2 In Maharashtra, Konkan area, the green pit viper (Trimeresurus gramineus) is uncommon, though this snake has become more common. [ Figure 1 ]

2014 ◽  
Vol 2 (3) ◽  
pp. 45-53 ◽  
Author(s):  
S Chaudhary ◽  
S Singh ◽  
N Chaudhary ◽  
SK Mahato

Snake-bite is one of the diseases which is included in the World Health Organization's (WHO) list of neglected tropical diseases. It is a well-known life threatening medical emergency commonly seen in farmers, plantation workers, herders, fishermen, snake restaurant workers and other food producers. In Nepal, snake-bite take a heavy toll of human lives. It is due to poor health services in rural areas especially for antisnake venom (ASV) treatment facility. Exact magnitudes of problem and mortality from snake-bite are very difficult to estimate due to serious misreporting. This review article aims to discuss the epidemiology, clinical features, diagnosis, treatment and prevention of snake-bite envenomation in South Asia region particularly in Nepal and helping in improving the knowledge and understanding of snake-bite to save precious human lives. DOI: http://dx.doi.org/10.3126/jucms.v2i3.11829 Journal of Universal College of Medical Sciences Vol.2(3) 2014: 45-53


2018 ◽  
Vol 1 (3) ◽  
pp. 220-222
Author(s):  
P O Echekwube ◽  
O A Abidakun

Onchocerciasis is a parasitic disease caused by the filarial worm Onchocerca volvulus. The disease is one of the Neglected Tropical Diseases which causes various cutaneous and extra-cutaneous disorders and creates a heavy burden on the sufferers. There is ongoing transmission of the disease despite all efforts at elimination mostly in rural communities. We report a case in a farmer who presented with features of chronic onchocerciasis and was further stigmatized in his community. Therefore, all efforts at elimination of the disease should be intensified.


2020 ◽  
Author(s):  
Cristhian David Morales-Plaza

Guarantee better clinical practices among clinicians who attend NTDs in developing countries as well as provide education in vector control in hotspot vulnerable communities


2020 ◽  
Vol 27 ◽  
Author(s):  
Kush K. Maheshwari ◽  
Debasish Bandyopadhyay

Background: Neglected tropical diseases (NTDs) affect a huge population of the world and majority of the victims belong to the poor community of the developing countries. Until now, the World Health Organization (WHO) has identified 20 tropical diseases as NTDs that must be addressed with high priority. However, many heterocyclic scaffolds have demonstrated potent therapeutic activity against several NTDs. Objective: There are three major objectives: (1) To discuss the causes, symptoms, and current status of all the 20 NTDs; (2) To explore the available heterocyclic drugs, and their mechanism of actions (if known) that are being used to treat NTDs; (3) To develop general awareness on NTDs among the medicinal/health research community and beyond. Methods: The 20 NTDs have been discussed according to their alphabetic orders along with the possible heterocyclic remedies. Current status of treatment with an emphasis on the heterocyclic drugs (commercially available and investigational) has been outlined. In addition, brief discussion of the impacts of NTDs on socio-economic condition is included. Results: NTDs are often difficult to diagnose and the problem is worsened by the unhealthy hygiene, improper awareness, and inadequate healthcare in the developing countries where these diseases primarily affect poor people. The statistics include duration of suffering, numbers affected, and access to healthcare and medication. The mechanism of actions of various heterocyclic drugs, if reported, have been briefly summarized. Conclusion: Scientists and pharmaceutical corporations should allocate more resources to reveal the in-depth mechanism of actions of many heterocyclic drugs that are currently being used for the treatment of NTDs. Analysis of current heterocyclic compounds and development of new medications can help in the fight to reduce/remove the devastating effects of NTDs. An opinion-based concise review has been presented. Based on available literature, this is the first effect to present all the 20 NTDs and related heterocyclic compounds under the same umbrella.


2014 ◽  
Vol 18 (20) ◽  
pp. 2572-2602 ◽  
Author(s):  
Rafael Espirito Santo ◽  
Marcella Machado ◽  
Jean Santos ◽  
Eduardo Gonzalez ◽  
Chung Chin

2020 ◽  
Vol 21 (12) ◽  
pp. 1250-1263
Author(s):  
Saurabh Shrivastava ◽  
Anshita Gupta ◽  
Chanchal Deep Kaur

Background: Lymphatic filariasis is a pervasive and life-threatening disease for human beings. Currently, 893 million people in 49 countries worldwide affected by lymphatic filariasis as per WHO statistics. The concealed aspects of lymphatic diseases such as delayed disease detection, inappropriate disease imaging, the geographical outbreak of infection, and lack of preventive chemotherapy have brought this epidemic to the edge of Neglected Tropical Diseases. Many medications and natural bioactive substances have seen to promote filaricidal activity against the target parasitic species. However, the majority of failures have occurred in pharmaceutical and pharmacokinetic issues. Objective: The purpose of the study is to focus on the challenges and therapeutic issues in the treatment of filariasis. The review brings novel techniques and therapeutic approaches for combating lymphatic filariasis. It also offers significant developments and opportunities for such therapeutic interventions. Conclusion: Through this review, an attempt has made to critically evaluate the avenues of innovative pharmaceuticals and molecular targeting approaches to bring an integrated solution to combat lymphatic filariasis.


Author(s):  
Jacob Stegenga

The book concludes by articulating what medical nihilism might entail for medical research, regulation, and treatment. There have been many proposed solutions to problems raised in this book, ranging from minor modifications to medical research (like requiring the registration of trials prior to data collection, and open access to trial data), to revolutionary changes (such as the complete socialization of medical research). These proposals for realigning medical research are evaluated, and proposals that are consistent with medical nihilism are articulated. These include stricter standards for detecting benefits and harms of medical interventions, a closer scrutiny of corporate research, and a shift in the research agenda away from barely effective pharmaceuticals toward projects with potential for greater impact, such as research on the importance of diet and exercise, and on neglected tropical diseases.


Sign in / Sign up

Export Citation Format

Share Document